Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Congress 2022: Industry Sponsored Satellite Symposia – NSCLC, Metastatic

ESMO-Congress-2022-1000x250

Friday 9 September

Advancing Tailored Therapies in NSCLC and KRASG12C-Driven Tumors

01-Advancing-Tailored-Therapies-in-NSCLC-and-KRAS-Driven-Tumors-MIRATI-thumb

Friday, 10:15 - 11:45
View the satellite invitation

Navigating Treatment Decisions in Advanced NSCLC: Update on Molecular Testing and New Targeted Treatment Options

06-Navigating-Treatment-Decisions-in-Advanced-NSCLC-ACE-ONCOLOGY-thumb

Friday, 10:15 - 11:45
View the satellite invitation

Navigating the Possibilities of Personalised Healthcare in Oncology

10-Navigating-the-Possibilities-of-Personalised-Healthcare-in-Oncology-ROCHE-thumb

Friday, 18:00 - 19:30
View the satellite invitation

Saturday 10 September

Precision Approaches in EGFR-Mutant NSCLC: Optimising Outcomes for Patients

18-Precision-Approaches-in-EGFR-Mutant-NSCLC-Optimising-Outcomes-for-Patients-JANSSEN-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

19-The-Treatment-Paradigm-Shift-Unlocking-New-Chapters-with-I-O-in-Thoracic-Cancers-BMS-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Connecting Patients Everywhere to Precision Oncology

23-Connecting-Patients-Everywhere-to-Precision-Oncology-THERMOFISHER-Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems

26-Breaking-Through-the-Firewall-BOEHRINGER-INGELHEIM-Thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Is It Time to Raise the Bar for ALK+ NSCLC Patients?

27-Is-It-Time-to-Raise-the-Bar-for-ALK-NSCLC-Patients-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Sunday 11 September

Redefining Lung Cancer Together: Now and Next

30-Redefining-Lung-Cancer-Together-Now-and-Next-ROCHE-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Advancing the Lung Cancer Treatment Landscape: Novel Targets for Improved Patient Care

31-Advancing-the-Lung-Cancer-Treatment-Landscape-AMGEN-Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Disrupting The Landscape: The Plus One in RCC and NSCLC

32-Disrupting-The-Landscape-The-Plus-One-in-RCC-and-NSCLC-IPSEN-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

The Current and Emerging Role of ADCs in Cancer Therapy

36-The-Current-and-Emerging-Role-of-ADCs-in-Cancer-Therapy-DAIICHI-Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

From Clinical Trial to Real-World Evidence: METex14 Inhibitors in Everyday Practice

43-From-Clinical-Trial-to-Real-World-Evidence-NOVARTIS-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 12 September

Decision-Making Discussions: IO in aNSCLC

52-Decision-Making-Discussions-IO-in-aNSCLC-SANOFI-REGENERON-thumb

Monday, 13:00 - 14:30
View the satellite invitation

Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

56-Targets-of-Antibody-Drug-Conjugates-in-NSCLC-MEDSCAPE-Thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.